logo
  

GATX Buys Over 18,500 Railcars From GE Capital Rail Services For About $340 Mln

Railcar leasing company GATX Corp. (GMT) said Monday that it has agreed to buy the North American per diem boxcar fleet of GE Capital Rail Services, a unit of diversified conglomerate General Electric Co. (GE), for about $340 million. The boxcar fleet consists of more than 18,500 boxcars.

Brian Kenney, president and chief executive officer of GATX said, "This fleet acquisition establishes GATX as the leader in the boxcar leasing market and adds a significant number of railcars to our fleet that are critical-use assets for certain important sectors of the North American economy."

According to Chicago, Illinois-based GATX, many of the customers utilizing this fleet are its existing customers and the acquisition will enable the company to meet the broad rail transportation needs of those customers.

GATX expects the acquired fleet to generate annual revenue of about $70 million. The company noted that the average age of the fleet is 34 years, relative to the statutory life of 50 years.

GMT closed Friday's trading at $66.00, up $0.85 or 1.30 percent on a volume of 294,630 shares.

GE closed Friday's trading at $25.40. In Monday's pre-market trades, the stock is up $0.14 or 0.56 percent to $25.54.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT